Department of Pathology
  Brigham and Women's Hospital
  A teaching Affliate of Harvard Medical School
Login Skip Navigation Links
  Skip Navigation Links
HomeExpand Home


Submit new announcement
David Michael Dorfman, M.D.,Ph.D.

Associate Professor of Pathology, Harvard Medical School

Academic Activities:

75 Francis Street
AL-2 Amory Building
Boston,MA 02115
Education and Training:

Medical School - : University of Iowa College of Medicine M.D.,Ph.D.
Residency 1986 - 1988 : Brigham and Women's Hospital
Fellowship 1991 - 1992 : Brigham and Women's Hospital
Residency 1992 - 1993 : Brigham and Women's Hospital
Fellowship 1988 - 1991 : Children's Hospital Boston

Clinical Specialties:
  • Hematopathology
  • Hematology
  • Anatomic Pathology
Research Interests:
  • Lymphoma
  • Cancer
  • Leukemia
  1. Weng AP, Shahsafaei A, Dorfman DM. CXCR4/CD184 immunoreactivity in T cell non-Hodgkin’s lymphomas with an overall Th1(-) Th2(+) immunophenotype. Am J Clin Pathol 2003; 119:424-430.
  2. Dorfman DM, Greisman HA, Shahsafaei A. Loss of expression of the WNT/beta-catenin signaling pathway transcription factors LEF-1 and TCF-1 in a subset of peripheral T cell lymphomas. Am J Pathol 2003; 1539-1544.
  3. Dorfman D.M., van den Elzen P., Weng A.P., Shahsafaei A., Glimcher L.H. Differential expression of T-bet, a T box transcription factor required for Th1 T cell development, in peripheral T cell lymphomas. Am J Clin Pathol 2003; 120:866-873.
  4. Dorfman DM, Hwang ES, Shahsafaei A, Glimcher LH. T cell-associated transcription factor T-bet is expressed in Hodgkin lymphoma. Human Pathology 2005; 36:10-15.
  5. Rodig SR, Shahsafaei A, Li B, Dorfman DM. The CD45 isoform B220 serves to identify a select subset of human B cells and B cell lymphoproliferative disorders. Human Pathology 2005; 36:51-57.
<September 2019>

<Sunday, September 15, 2019>
Copyright 2008 - 2019, BWH Pathology, All rights reserved.